Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: JMarcus who wrote (536)	3/4/2004 1:39:39 PM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

Marc: Re: POTP Its making a new 52wks. H for its second day on a roll.<g> Yesterday it was able to close above its Feb.19 H of 6.45 The recent high volume on Feb.27 (637.6K) was to the upside, and a little higher than its previous H volume on Nov.5 (615.4K) that was also to the upside.<g> The results for the 4thQ and year ended December 31 weren't bad, as it completed a P1 on chemotherapy-induced neutropenia and started a P1/2 Rituxan study on patients with hematologic malignancies,which showed it had some potential as an anti-tumor therapy. POTP raised $11.2M in a private placement last year. After its first spike in May last year, the volume has increased to the upside and accelerated since September. bigcharts.marketwatch.com If it continues on its present momentum, it seems that the stock has potential to test the $10 level this year.<g> bigcharts.marketwatch.com Bernard